sunvozertinib
dizal pharmaceuticals
['sunvozertinib']
#asco22 sunvozertinib in #egfrex20 showed rr 40%, mdor 5.9m, more dose reduction if prior io but not a higher rate of g3 aes (hope to see breakdown of iraes etc) 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him